Intact and C-Terminal FGF23 Assays-Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?

Shilpa Sharma, Ronit Katz, Alexander L. Bullen, Paulo H. M. Chaves, Peter W. de Leeuw, Abraham A. Kroon, Alfons J. H. M. Houben, Michael G. Shlipak, Joachim H. Ix*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number665
Number of pages11
JournalJournal of Clinical Endocrinology & Metabolism
Volume105
Issue number12
DOIs
Publication statusPublished - Dec 2020

Keywords

  • FGF23
  • assays
  • mortality
  • inflammation
  • kidney function
  • iron deficiency
  • GROWTH-FACTOR 23
  • STAGE RENAL-DISEASE
  • ALL-CAUSE MORTALITY
  • CARDIOVASCULAR EVENTS
  • FACTOR-23
  • FIBROBLAST-GROWTH-FACTOR-23
  • PREDICTOR
  • MARKERS
  • DEATH
  • RISK

Cite this